Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancer (vol 131, pg 169, 2013)

作者:Anwer Khursheed*; Kelly F Joseph; Chu Christina; Fewell Jason G; Lewis Danny; Alvarez Ronald D
来源:Gynecologic Oncology, 2014, 134(1): 216-216.
DOI:10.1016/j.ygyno.2014.04.048